📣 VC round data is live. Check it out!
- Public Comps
- Integrum
Integrum Valuation Multiples
Discover revenue and EBITDA valuation multiples for Integrum and similar public comparables like Promimic, Cambridge Cognition, NanoRepro, Modular Medical and more.
Integrum Overview
About Integrum
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
Founded
1990
HQ

Employees
19
Website
Financials (FY)
EV
$19M
Valuation Multiples
Start free trialIntegrum Financials
Integrum reported last fiscal year revenue of $10M and negative EBITDA of ($4M).
In the same fiscal year, Integrum generated $8M in gross profit, ($4M) in EBITDA losses, and had net loss of ($3M).
Revenue (LTM)
Integrum P&L
In the most recent fiscal year, Integrum reported revenue of $10M and EBITDA of ($4M).
Integrum is unprofitable as of last fiscal year, with gross margin of 83%, EBITDA margin of (38%), and net margin of (30%).
Financial data powered by Morningstar, Inc.
Integrum Stock Performance
Integrum has current market cap of $22M, and enterprise value of $19M.
Market Cap Evolution
Integrum's stock price is $0.81.
Integrum share price decreased by 4.3% in the last 30 days, and by 57.4% in the last year.
Integrum has an EPS (earnings per share) of $-0.11.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19M | $22M | -0.4% | -4.3% | -15.2% | -57.4% | $-0.11 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIntegrum Valuation Multiples
Integrum trades at 1.9x EV/Revenue multiple, and (5.0x) EV/EBITDA.
EV / Revenue (LTM)
Integrum Financial Valuation Multiples
As of May 9, 2026, Integrum has market cap of $22M and EV of $19M.
Integrum has a P/E ratio of (7.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Integrum Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Integrum Margins & Growth Rates
In the most recent fiscal year, Integrum reported gross margin of 83%, EBITDA margin of (38%), and net margin of (30%).
Integrum Margins
Integrum Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Integrum Operational KPIs
Integrum's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.7M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Integrum Competitors
Integrum competitors include Promimic, Cambridge Cognition, NanoRepro, Modular Medical, Biosynex, Genomtec, Icecure Medical, Medclair, Bioretec and Pulsenmore.
Most Integrum public comparables operate across Medical Devices, HealthTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.1x | — | (92.3x) | — | |||
| 1.7x | 1.6x | (32.3x) | 208.7x | |||
| 2.5x | 0.7x | (3.5x) | (9.6x) | |||
| — | — | (1.0x) | — | |||
| 0.7x | — | (3634.5x) | — | |||
| 79089.9x | — | (9.1x) | — | |||
| 3.2x | 2.3x | (0.7x) | — | |||
| 4.2x | — | 21.2x | — | |||
This data is available for Pro users. Sign up to see all Integrum competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Integrum
| When was Integrum founded? | Integrum was founded in 1990. |
| Where is Integrum headquartered? | Integrum is headquartered in Sweden. |
| How many employees does Integrum have? | As of today, Integrum has over 19 employees. |
| Is Integrum publicly listed? | Yes, Integrum is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Integrum? | Integrum trades under INTEG B ticker. |
| When did Integrum go public? | Integrum went public in 2017. |
| Who are competitors of Integrum? | Integrum main competitors include Promimic, Cambridge Cognition, NanoRepro, Modular Medical, Biosynex, Genomtec, Icecure Medical, Medclair, Bioretec, Pulsenmore. |
| What is the current market cap of Integrum? | Integrum's current market cap is $22M. |
| What is the current revenue of Integrum? | Integrum's last fiscal year revenue is $10M. |
| What is the current EV/Revenue multiple of Integrum? | Current revenue multiple of Integrum is 1.9x. |
| Is Integrum profitable? | No, Integrum is not profitable. |
| How many companies Integrum has acquired to date? | Integrum hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Integrum has invested to date? | Integrum hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Integrum
Lists including Integrum
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.